Form D — Eikon Therapeutics, Inc.
0001861123-25-000001 · filed 2025-02-28
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $399,999,934
- Total sold
- $350,700,037
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Eikon Therapeutics, Inc.
- CIK
- 1861123
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3929 POINT EDEN WAY
HAYWARD, CA 94545 - Phone
- 415-865-2050
Related persons
-
Roger M. Perlmutter · Executive OfficerHayward, CA Find on LinkedIn ↗
-
Dror Berman · DirectorHayward, CA Find on LinkedIn ↗
-
Leon Chen · DirectorHayward, CA Find on LinkedIn ↗
-
Joshua Wolfe · DirectorHayward, CA Find on LinkedIn ↗
-
James Tananbaum · DirectorHayward, CA Find on LinkedIn ↗
-
Kenneth Frazier · DirectorHayward, CA Find on LinkedIn ↗
-
Robin Washington · DirectorHayward, CA Find on LinkedIn ↗
-
Robbie Huffines · DirectorHayward, CA Find on LinkedIn ↗
View original on SEC EDGAR.